Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pandox in connection with a directed share issue of SEK 2 billion
Mandate

Vinge has advised Pandox in connection with a directed share issue of SEK 2 billion

September 18, 2024

Vinge has advised the hotel property owner Pandox Aktiebolag (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 2 billion before transaction costs.

The company intends to use the proceeds to maintain the company’s strong financial position following hotel acquisitions in London and Edinburgh and to increase the company’s financial flexibility for additional property acquisitions and investments in existing properties. The Pandox share is listed on Nasdaq Stockholm.

Vinge’s team consisted of Jesper Schönbeck, Joel Magnusson, Adrian Filipovic and Maximilian Bengtsson.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026